How mRNA Vaccines could Target Everything from Cancer to the Plague?
Eric Spitznagel, New York Post, Health, March 25, 2023. Scientists Edo Kon and Dan Peer from Tel Aviv University and the Israel Institute for Biological Research announced that they’d created a single-dose vaccine that could effectively protect people from Yersinia pestis bacterium. Haven’t heard of it? That’s because it’s better known (at least in the […]
Israeli Scientists Produce World’s First mRNA Vaccine for Bacteria
https://www.youtube.com/watch?v=2Fyhk_6GmsQ Researchers from Tel Aviv University and the Israel Institute for Biological Research have developed the world’s first mRNA vaccine effective against bacteria. By modifying proven mRNA technology used to fight COVID and other viral pathogens, the scientists developed a single-dose vaccine that fully protects mice against the Plague, the lethal disease that killed millions of people […]
Dana Tarab-Ravski Lior Stotsky-Oterin – CBRC 4th Graduate Student Awards
Congratulation to our Ph.D. Students, Dana Tarab-Ravski and Lior Stotsky-Oterin for receiving the CBRC Excellent Achievements Prize in Cancer Research 2022.
Dual–Targeted Lipid Nano-therapeutic Boost for Chemo–Immunotherapy of Cancer
Researchers from Tel Aviv University proved that a drug delivery system based on lipid nanoparticles can utilize RNA to overcome resistance to both chemotherapy and immunotherapy in cancer treatments. The study opens a new path to a personalized and precisely targeted battle against cancer. The results were published in the scientific journal Advanced Materials. The […]
Israeli Scientists Kill Cancer With Revolutionary DNA-Altering Treatment
Tel Aviv University researchers use tiny ‘molecular scissors’ to target aggressive metastatic cancer cells. Israeli scientists have developed a cutting-edge nanotechnology system that can destroy cancerous cells in mice. The Tel Aviv University team of researchers pioneered a treatment method that is so precise, it is almost as if tiny molecular scissors were being used […]
TAU Develops Targeted Delivery of Therapeutic RNAs to Cancer Cells Only
Prof. Peer says , “We were able to organize the delivery system in such a way that we target to only 14.9% of the cells that were involved in the inflammatory condition of the disease, without adversely affecting the other, non-involved, cells, which are completely healthy. Through specific binding to the cell sub-population, while delivering […]
A Matter of Time- mRNA Technology, Lipid Nanoparticles and Bioinformatics have turned the pharmaceutical industry upside-down
“without lipid nanoparticles, there is no mRNA vaccine, no 95% efficacy, and the route out of the pandemics is many times longer and narrower”. Tim Guns speaks to Robert langer, MIT institute, and Moderna cofounder, Pieter Cullis, head of the Nanomedicine Research group at the University of British Columbia and co-founder of Acutias, and Dan […]
Team Award Winners: Infinite Possibilities Teams Awards
The 2021 MolecularCloud Distinguished Research Awards for outstanding research achievements in the genome-editing field. Team Award Winners – The Peer Dan Team- Infinite Possibilities Teams The lab is highly dynamic, multidisciplinary, and focuses on developing targeted vehicles for cell-specific delivery of novel molecular medicines using RNAi, mRNA, saRNA, DNA, and novel genome editing strategies. Our goal […]
Handbook of Harnessing Biomaterials in Nanomedicine Edited By Dan Peer
See our new edition of the handbook Harnessing Biomaterials in Nanomedicine, edited by Prof. Dan Peer. https://www.taylorfrancis.com/books/handbook-harnessing-biomaterials-nanomedicine-dan-peer/e/10.1201/9781003125259
Design of mRNA vaccines delivered via novel lipid nanoparticles
Elia U, Ramishetti S, Rosenfeld R, Dammes N, Bar-Haim E, Somu Naidu G, Makdasi E, Yahalom-Ronen Y, Tamir H, Paran N, Cohen O, Peer D